ZERIA PHARMACEUTICAL CO.,LTD.(4559) News

[Updated]Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2026[Under Japanese GAAP]

[Summary] Financial Results for the First Six Months of the Fiscal Year Ending March 31,2026

Notice regarding Cancellation of Treasury Shares

ZERIA PHARMA, First Half Ordinary Profit Decreases by 67%, Jul-Sep Ordinary Profit Decreases by 60%

Notice regarding Revision of Consolidated Earnings Forecast

ZERIA PHARMA, Ordinary Profit Forecast for First Half Revised Downward by 47%

[Updated]Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31,2026(Under Japanese GAAP)

[Summary] Financial Results for the First Three Months of the Fiscal Year Ending March 31,2026

Notice regarding Cancellation of Treasury Shares

ZERIA PHARMA, Apr-Jun (1Q) Ordinary Profit Decreases by 70%

[Updated]Consolidated Financial Results for the Fiscal Year Ended March 31,2025(Under Japanese GAAP)

Notice Concerning Dividends from Surplus(Increase)

Notice of Changes in Executive Officers

[Summary] Financial Results for the Year

ZERIA PHARMA, 7% Decrease in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 1 yen, This Fiscal Year to Increase Dividend by 1 yen

[Delayed]Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31,2025[Under Japanese GAAP]

Summary of Financial Results for the third quarter 2025

ZERIA PHARMA, The Current Fiscal Year Ordinary Profit Revised Upward by 9%, Raises Record High Profit Forecast

[Delayed]Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2025[Under Japanese GAAP]

Summary of Financial Results for the second quarter 2025